Category

Press releases

Latest news

« AGS Therapeutics Strenghtens its Patent Portfolio on Microalgae Extracelluar Vesicles (MEV) with an International Patent Application on Preparation and Uses of MEVs as a Universal Drug Delivery System », Paris, FR, Mai 8, 2023

« AGS Therapeutics Unveils Ambitious R&D Pipeline, Showcasing the Potential of its Universal Delivery System for Novel Therapeutics », Paris, FR, April 4, 2023

« Novel drug delivery system to overcome barriers | AGS Therapeutics to Present at BIO CEO & Investor Conference NYC », Paris, FR, February 6, 2023